Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: Texarkana, TX-Texarkana, AR MSA — October 2026
Texarkana's thin labor pool collides with statewide biopharma hiring surge.
Texarkana's labor force added just 555 workers through August even as Texas biopharma postings jumped 53% year-over-year, with local CRA pay trailing the national median by over $11,000.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Texarkana MSA unemployment: 4.5% — Down from 4.8% in July; vs 4.1% nationally
- Labor force growth, YTD: +0.4% — Just 250 workers added Jan–Aug 2026
- Texas biopharma job postings: +53% YoY — Jan–Aug 2026, outpacing hiring capacity statewide
- Texarkana nonfarm employment: 60,200 — August 2026, down slightly from 60,300 in June
Key takeaways
Regulatory Affairs pay is softening locally against a tightening labor pool.
Advertised metro pay for Regulatory Affairs Specialist fell to $95,473 even as national demand for regulatory talent is described as among the hardest to fill in 2026. Locally declining pay amid high-level scarcity elsewhere may signal under-recruitment risk if demand catches up to national patterns.
Biostatistician pay in Texarkana now outpaces the national figure.
Metro median of $139,166 exceeds the national $131,958, an unusual inversion for a small metro. Worth confirming whether this reflects a thin sample of postings or a real local premium before using it to set offers.
Clinical Research Associate pay gap with national rates has widened.
Metro CRA pay sits at $78,893 against a national median of $90,065, even as CRAs remain the chokepoint role nationally for clinical operations. A metro this far below national levels risks losing experienced CRAs to remote postings or larger Texas markets.
A 60,200-job metro cannot source specialized talent the way Houston or Dallas can.
Modest labor force growth (+0.4%) and a small nonfarm base limit the pipeline for credentialed R&D and quality staff. Decisions on CRO/CDMO partnerships should account for this metro's shallow bench rather than assume commuting-distance hiring will close gaps.
Median advertised pay by role — Texarkana, TX-Texarkana, AR MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $82,765 | $123,070 | $131,979 | Significant increase | $130,339 |
| Clinical Research Associate * | $57,977 | $78,893 | $95,462 | Moderate increase | $90,065 |
| Lab Technician * | $38,082 | $45,670 | $49,588 | Stable | $47,840 |
| Regulatory Affairs Specialist * | $70,793 | $95,473 | $116,373 | Moderate decline | $103,780 |
| Clinical Data Manager * | $96,453 | $122,953 | $135,700 | Stable | $123,653 |
| Biostatistician * | $98,485 | $139,166 | $160,691 | Moderate increase | $131,958 |
| Validation Engineer * | $82,756 | $104,143 | $112,977 | Moderate increase | $106,478 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Texarkana MSA unemployment eased to 4.5% in August, down from 4.8% in July, with civilian labor force rising to 62,108 by September — a tightening local labor pool even as the rate sits above the 4.1% national reading. Bowie County's highest-paying occupation cluster remains Healthcare Practitioners and Technical Occupations at $101,700, signaling that scientific and technical credentials already command a premium in a metro where total nonfarm employment holds near 60,200 and growth is incremental rather than broad-based.
What it means
Thin local labor force gains (just 555 added jobs January–August) mean life sci employers in this metro cannot rely on organic population growth to fill specialized R&D, quality, or regulatory roles, reinforcing the national pattern of a 1.9% quit rate and candidates staying put. A metro this size offers limited bench depth for niche credentials like CRAs or validation engineers, making build-vs-outsource tradeoffs with CROs and CDMOs more consequential here than in larger Texas life sci hubs like Houston or Austin. Organizations should evaluate whether critical science and quality roles are better secured through remote or hybrid arrangements tied to regional pay data rather than assuming local sourcing alone will meet headcount plans.
Looking ahead
Expected: BLS October metro data releases in early November; watch whether the unemployment rate continues its August–September decline or reverses, which would signal whether local talent supply is loosening or tightening further.
Emerging pressure point: Statewide biopharma job postings surged 53% year-over-year while Texarkana's labor force barely moved, widening the gap between demand signals and local supply. Monitor whether this pushes more employers toward remote regulatory and data roles sourced outside the metro.
Worth watching: Regulatory Affairs advertised pay has moved down locally and nationally this month even as the role is flagged as hard-to-fill — a divergence worth tracking for whether it corrects or persists into Q1 2027 hiring cycles.
Potential inflection point: Texas WARN filings are down 35% year-over-year, with no major life sci-specific layoffs locally reported. Any shift toward manufacturing or distribution-sector WARN activity near Bowie County would be worth monitoring as a potential source of transferable quality or operations talent.
Sources
- Bureau of Labor Statistics / NETX Workforce — Texarkana MSA unemployment rate at 4.5% in August 2026
- Bureau of Labor Statistics — Bowie County top-paying occupation group wages
- Industry labor market research notes — National quit rate at 1.9% amid biopharma hiring recovery
- Texas life sciences labor market research — Texas biopharma job postings up 53% YoY Jan-Aug 2026
- Bureau of Labor Statistics — Texarkana labor force increased by 250 workers Jan-Aug 2026
- Texas Workforce Commission — Texas WARN notices down 35% YoY through October 2026
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.